EarliPoint Health Launches Skill Illustrator™ to Help Providers Translate Assessment Data into Actionable Developmental Insights.

Read Release →

Articles

Exploring the science, practice, and people shaping the future of early developmental evaluation.

EarliPoint Receives FDA Clearance to Expand Autism Diagnosis and Assessment Up to Age 8

Expanded indication enables broader access to objective, biomarker-based autism assessment and measurement of outcomes over time Plymouth, MN, March 12, 2026 — […]

…

Local SEO for ABA Therapy Providers: A Step-by-Step Guide

Most ABA practices have a website. Most have a Google Business Profile. And most are invisible to the families who need them. […]

…

When “Not Listening” Reflects Differences in Social Processing

A child who does not follow directions can look, from the outside, like a child who is choosing not to. The instruction […]

…

Does Your Baby Avoid Eye Contact? Here’s What It Could Mean

If your baby avoids eye contact, turns away when you look at them, seems to gaze past you, or doesn’t hold your […]

…

Why Won’t My Child Look at Me?: Looking Away May Help Children With Autism Listen

You ask your child a question. They don’t look at you. Their gaze drifts to the corner of the room, or the […]

…

They Talk So Well With Adults, So Why Not With Other Kids?

Parents ask me about this all the time. Their child can have a long, detailed conversation with an adult about weather systems, […]

…
Request A Demo

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder